Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000112595 | SCV001161516 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2019-06-18 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 7.78E-06 |
National Health Laboratory Service, |
RCV002222163 | SCV002025903 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505024 | SCV002808601 | likely benign | Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000501985 | SCV003917924 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | BRCA1: BS1 |
Breast Cancer Information Core |
RCV000112595 | SCV000145431 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2000-08-09 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000501985 | SCV000591604 | likely benign | not provided | no assertion criteria provided | clinical testing | The BRCA1 c.5277+78G>A variant has not been reported in the literature nor previously identified by our laboratory. This is an intronic variant, which occurs outside the consensus splice site sequences, and is not found to impact on splicing using the prediction programs. It is listed in the dbSNP database from a clinical source with no information on the population frequency. Based on the information above, this variant is likely benign. |